In contrast, other protein samples used for the selectivity study (i.e., interleukin‐6 (IL‐6), C‐reactive protein (CRP), cardiac Troponin I (cTnI), and brain natriuretic peptide (BNP)) displayed negative resistance changes on COVID‐19 nanoMIPs. The gene discussed is TNNI3; the disease is COVID-19.